Cost burden of GI events following opioid use “substantial” Clinical study 17 January 2013 Pages: 1 - 1
The US FDA has raised the possibility that long-acting exenatide may be associated with an increased cancer risk Media release 17 January 2013 Pages: 2 - 2
Unpublished data from a retrospective study have raised concerns about the risk of cancer in patients using becaplermin [Regranex] Clinical study 17 January 2013 Pages: 3 - 3
Atypical fractures not typical enough for definitive conclusions Clinical study 17 January 2013 Pages: 3 - 3
Over 900 packs of Jingzhi Kesou Tan Chuan Wan remain in circulation in the UK, despite safety warnings from the UK MHRA Media release 17 January 2013 Pages: 3 - 3
Biogen Idec hopes to launch a test to determine a patient’s odds of developing progressive multifocal leukoencephalopathy Media release 17 January 2013 Pages: 3 - 3
